Oncology in France

François-Clément Bidard, MD, PhD, is a leading medical oncologist in France, specializing in breast cancer treatment and research. As a Professor of Medicine at Institut Curie & Université Paris-Saclay, he is renowned as one of the best breast cancer specialists in France, with expertise in metastatic breast cancer, tumor biomarkers, and circulating tumor DNA (ctDNA). Dr. Bidard is the co-coordinator of breast cancer research at Institut Curie, the #1 breast cancer center in France, and serves as the Vice-Chair of Unicancer's Breast Cancer Research Group (UCBG). With a distinguished career in oncology, he has contributed extensively to cutting-edge cancer research and personalized treatments, particularly in liquid biopsy techniques and early cancer detection. His pioneering work in ctDNA and circulating tumor cells (CTCs) has positioned him among the top oncologists in Paris and a famous cancer researcher in Europe, making him a trusted name in breast cancer treatment.

Dr. Sofie Broker, a leading oncologist in France, has over 20 years of experience in oncology and cancer treatment. She practices at the prestigious Institut Curie Hospital in Paris, where she provides comprehensive consultations and cutting-edge therapies for patients battling various forms of cancer. Recognized as one of the top cancer specialists in Paris, she extends her expertise beyond traditional settings by offering online cancer consultations, ensuring accessibility to patients worldwide.

Prof. Nicolas Girard is a leading thoracic oncologist and famous respiratory medicine expert, specializing in the treatment of lung cancer, neuroendocrine tumors, and thymic malignancies. As a top lung cancer specialist, he plays a pivotal role in shaping perioperative strategies, managing locally advanced thoracic cancers, and pioneering targeted therapies for oncogene-addicted tumors. Prof. Girard currently serves as the Head of the Curie-Montsouris Thorax Institute and Chair of the Medical Oncology Department at Institut Curie, Paris, while also holding an academic position as Professor of Respiratory Medicine at Versailles Saint-Quentin University. Recognized as the best thymic tumor doctor in France, his groundbreaking contributions to rare thoracic cancer research and clinical advancements in EGFR-mutant NSCLC treatment have earned him global recognition.